This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (106)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Public Health  • Substance Abuse/ Alcoholism  • Alert me on articles by topic

Marilyn A. Huestis, PhD; David A. Gorelick, MD, PhD; Stephen J. Heishman, PhD; Kenzie L. Preston, PhD; Richard A. Nelson, MD; Eric T. Moolchan, MD; Richard A. Frank, MD, PhD

Arch Gen Psychiatry. 2001;58:322-328.

Background  SR141716, a recently developed CB1 cannabinoid receptor antagonist, blocks acute effects of -9-tetrahydrocannabinol (THC) and other CB1 cannabinoid agonists in vitro and in animals. These findings suggest that CB1 receptors mediate many of the effects of marijuana, but this has not been evaluated in humans.

Methods  Sixty-three healthy men with a history of marijuana use were randomly assigned to receive oral SR141716 or a placebo in an escalating dose (1, 3, 10, 30, and 90 mg) design. Each subject smoked an active (2.64% THC) or placebo marijuana cigarette 2 hours later. Psychological effects associated with marijuana intoxication and heart rate were measured before and after antagonist and marijuana administration.

Results  Single oral doses of SR141716 produced a significant dose-dependent blockade of marijuana-induced subjective intoxication and tachycardia. The 90-mg dose produced 38% to 43% reductions in visual analog scale ratings of "How high do you feel now?" "How stoned on marijuana are you now?" and "How strong is the drug effect you feel now?" and produced a 59% reduction in heart rate. SR141716 alone produced no significant physiological or psychological effects and did not affect peak THC plasma concentration or the area under the time x concentration curve. SR141716 was well tolerated by all subjects.

Conclusions  SR141716 blocked acute psychological and physiological effects of smoked marijuana without altering THC pharmacokinetics. These findings confirm, for the first time in humans, the central role of CB1 receptors in mediating the effects of marijuana.

From the Clinical Pharmacology and Therapeutics Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Md (Drs Huestis, Gorelick, Heishman, Preston, Nelson, and Moolchan); and Sanofi-Synthelabo Inc, Malvern, Pa (Dr Frank).

Corresponding author and reprints: Marilyn A. Huestis, PhD, National Institute on Drug Abuse Intramural Research Program, 5500 Nathan Shock Dr, Baltimore, MD 21224 (e-mail: mhuestis{at}intra.nida.nih.gov).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by {Delta}9-tetrahydrocannabinol
Springs et al.
J. Leukoc. Biol. 2008;84:1574-1584.
ABSTRACT | FULL TEXT  

Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids
Strougo et al.
J Psychopharmacol 2008;22:717-726.
ABSTRACT  

Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
Potvin et al.
J Psychopharmacol 2008;22:262-269.
ABSTRACT  

Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex
Bambico et al.
J. Neurosci. 2007;27:11700-11711.
ABSTRACT | FULL TEXT  

Clinical Advances in Pharmacological and Integrated Treatment Approaches for Alcohol and Drug Use Disorders
Dermatis and Galanter
Focus 2007;5:141-150.
ABSTRACT | FULL TEXT  

Interventions for cannabis misuse
Maddock and Babbs
Adv. Psychiatr. Treat. 2006;12:432-439.
ABSTRACT | FULL TEXT  

The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto et al.
Endocr. Rev. 2006;27:73-100.
ABSTRACT | FULL TEXT  

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
Gobbi et al.
Proc. Natl. Acad. Sci. USA 2005;102:18620-18625.
ABSTRACT | FULL TEXT  

Estimating the Time of Last Cannabis Use from Plasma {Delta}9-Tetrahydrocannabinol and 11-nor-9-Carboxy-{Delta}9-Tetrahydrocannabinol Concentrations
Huestis et al.
Clin. Chem. 2005;51:2289-2295.
ABSTRACT | FULL TEXT  

Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Le Foll and Goldberg
J. Pharmacol. Exp. Ther. 2005;312:875-883.
ABSTRACT | FULL TEXT  

Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use
Chiang et al.
Hum Mol Genet 2004;13:2113-2119.
ABSTRACT | FULL TEXT  

Effect of Acute Marijuana on Cardiovascular Function and Central Nervous System Pharmacokinetics of [15O]Water: Effect in Occasional and Chronic Users
Ponto et al.
J Clin Pharmacol 2004;44:751-766.
ABSTRACT | FULL TEXT  

Cannabis and the brain
Iversen
Brain 2003;126:1252-1270.
ABSTRACT | FULL TEXT  

Evidence-Based Treatments for Substance Use Disorders
Gold and Brady
Focus 2003;1:115-122.
ABSTRACT | FULL TEXT  

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter et al.
J. Neurosci. 2003;23:1398-1405.
ABSTRACT | FULL TEXT  

Oculomotor Effects of {delta}-9-Tetrahydrocannabinol in Humans: Implications for the Functional Neuroanatomy of the Brain Cannabinoid System
Ploner et al.
Cereb Cortex 2002;12:1016-1023.
ABSTRACT | FULL TEXT  

A missense mutation in human fatty acid amide hydrolase associated with problem drug use
Sipe et al.
Proc. Natl. Acad. Sci. USA 2002;99:8394-8399.
ABSTRACT | FULL TEXT  

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett et al.
Pharmacol. Rev. 2002;54:161-202.
ABSTRACT | FULL TEXT  

Cannabinoid Receptor Antagonist Blocks Marijuana Intoxication...
JWatch Psychiatry 2001;2001:5-5.
FULL TEXT  

Cannabinoid Antagonists: A Treatment in Search of an Illness
D'Souza and Kosten
Arch Gen Psychiatry 2001;58:330-331.
FULL TEXT